Arrowhead Conferences bring together thought leaders and high-level executives from throughout the biotech and pharmaceutical industries. Our conferences tackle the issues and trends that are shaping the future of healthcare, including advances in drug discovery, clinical development, strategic alliances, new technologies and business development.

Arrowhead can design tailor-made sponsorship and/or exhibitor packages that can help grow your businesses through direct and targeted exposure to industry leaders and decision makers.

To gain critical exposure via sponsorship and exhibiting opportunities, please contact marketing@arrowheadpublishers.com or call us at 312-244-3703


Sponsors


MD Biosciences offers products and preclinical in vitro and in vivo services in the areas of Neurology and Inflammation. Areas specifically focused on include Nociceptive, Neuropathic and Inflammatory Pain, Multiple Sclerosis, Alzheimer’s, Parkinsons, Arthritis, Allergic Asthma, IBD as well as mode of action studies. MD Biosciences employs a panel of scientific experts in these fields providing researchers the in-depth expertise needed to tackle problems and provide flexible drug discovery solutions.



For almost 30 years, Product Safety Labs (PSL) has provided research and testing services to the agrichemical, chemical, pharmaceutical, dietary supplement/functional foods, personal care, animal health, biotechnology and household product industries. We offer a broad range of services including toxicology, analytical and bioanalytical chemistry and pharmacology.



The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARSĀ®) System is a prescription drug abuse, misuse and diversion surveillance system that provides time, product, and geographically-specific data.

The RADARS System measures rates of abuse, misuse and diversion throughout the United States , contributing to the understanding of trends and aiding the development of effective interventions. These data can assist pharmaceutical companies in fulfillment of their regulatory obligations such as risk minimization action plans. www.radars.org